Table 3:
Group 1(HM3) (n=19) |
Group 2 (n=85) |
p-value | |
---|---|---|---|
30 Day Mortality | 0 (0%) | 9 (10.6%) | 0.21 |
90 Day Mortality | 0 (0%) | 15 (17.6%) | 0.07 |
Dialysis Post-op | 1 (5.3%) | 16 (18.8%) | 0.19 |
RV Dysfunction Post-op | 0.47 | ||
None | 2 (10.5%) | 14 (16.5%) | |
Mild | 3 (15.8%) | 23 (27.1%) | |
Moderate | 8 (42.1%) | 33 (38.8%) | |
Severe | 6 (31.6%) | 15 (17.6%) | |
Hospital LOSa | |||
Median [Min, Max] | 24.0 [12.0, 226] | 27.0 [7.00, 165 | 0.51 |
ICU LOSq | |||
Median [Min, Max] | 7.00 [3.00, 223] | 13.5 [2.00, 165] | 0.32 |
Number of Readmissions per 365 Days of VAD Support | |||
Median [Min, Max] | 1.85 [0.00, 12.4] | 2.03 [0.00, 23.4] | 0.28 |
NYHA Postop | 0.67 | ||
NYHA I | 2 (10.5%) | 16 (18.8%) | |
NYHA II | 10 (52.6%) | 33 (38.8%) | |
NYHA III | 4 (26.3%) | 15 (17.6%) | |
NYHA IV | 1 (10.5%) | 4 (4.7%) | |
Missing | 0 (0%) | 17 (20%) | |
LOS, length of stay; RV, right ventricular; NYHA, New York Heart Association; ICU, intensive care unit; VAD, ventricular assist device;
days